Cara Haymaker PhD

Cara L. Haymaker PhD is an Associate Professor in the Department of Translational Molecular Pathology at the University of Texas MD Anderson Cancer Center. Her lab is focused on defining the tumor immune microenvironment including tumor-infiltrating lymphocytes (TIL) in malignant pleural mesothelioma and identifying actionable targets in this rare tumor. In addition, her lab is investigating ways to modulate intratumoral APCs to improve antigen presentation and costimulation to TIL, thus improving response to cellular and antibody-based immunotherapy strategies.

Dr. Haymaker is also actively involved in immune profiling of clinical trials performed at UT MDACC as Director of both the Translational Molecular Pathology-Immunoprofiling Lab (TMP-IL) and the CCSG developmental Oncology Research and Immune-monitoring core (ORION).